What are the salient histopathological features in Antibody-Mediated Rejection (AMR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The salient histopathological features in Antibody-Mediated Rejection (AMR) include C4d deposition along peritubular capillaries, microvascular inflammation, and the presence of complement components such as C3d, which are critical for diagnosing AMR. These features are characterized by the presence of C4d and C3d, which are complement split products that bind covalently to endothelium at the site of complement activation, as noted in a study published in Circulation in 2015 1. The histological changes of AMR may be seen in any vessel type, but C4d deposition is largely restricted to capillaries, with occasional staining of large-vessel endothelium, perimyocytes, or sarcolemma, although these patterns do not appear to indicate AMR 1. Some key points to consider in the diagnosis of AMR include:

  • C4d positivity is used frequently to diagnose AMR, and some authors suggest that C4d can be used as an immunopathologic surrogate for AMR 1
  • The combination of C4d and C3d detected by immunofluorescence predicts graft dysfunction and mortality better than C4d alone 1
  • The presence of C3d, a complement split product, is also used to diagnose AMR, and it indicates progression of complement activation 1
  • Histological changes of AMR may be seen in any vessel type, but C4d deposition is largely restricted to capillaries 1. Overall, the diagnosis of AMR relies on a combination of histological features, including C4d deposition, microvascular inflammation, and the presence of complement components, as well as clinical graft dysfunction and circulating donor-specific antibodies.

From the Research

Histopathological Features of Antibody-Mediated Rejection (AMR)

The salient histopathological features of AMR include:

  • Microvascular inflammation, such as glomerulitis and peritubular capillaritis 2
  • Thrombosis or neutrophils or mononuclear leukocytes in capillary lumens 3
  • Edema, hemorrhage, necrosis, mild inflammation, and neutrophils or mononuclear leukocytes in the peritubular capillary lumens 3
  • Thrombosis, thrombotic microangiopathy, fibrinoid necrosis, or transmural vasculitis in blood vessels 3
  • Strong staining for C4d in the peritubular capillaries, which is characteristic of AMR 3, 4
  • Transplant glomerulopathy (TG) and peritubular capillary basement membrane multilayering (PTCBMML) in chronic active AMR (CAAMR) 2

Diagnostic Criteria for AMR

A definitive diagnosis of AMR requires:

  • Morphologic evidence of acute tissue injury 3
  • Immunopathologic evidence for antibody action, such as C4d staining 3, 4
  • Serologic evidence of circulating donor-specific antibodies 3, 5 In the absence of all three criteria, AMR should be suspected if some but not all criteria are met 3

Organ-Specific Features of AMR

AMR can occur in various organs, including:

  • Kidney: characterized by microvascular inflammation, thrombosis, and C4d staining 3, 2, 5
  • Liver: characterized by biliary obstruction-like features, C4d staining, and donor-specific antibodies 4
  • Lung: characterized by microvascular inflammation, C4d staining, and acute lung injury 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibody-mediated rejection in the liver allograft.

Current opinion in organ transplantation, 2012

Research

Antibody-mediated rejection and treatment in pediatric patients: one center's experience.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.